|
1
|
Pan G, Ni J, Wei YF, Yu G, Gentz R and
Dixit VM: An antagonist decoy receptor and a death
domain-containing receptor for TRAIL. Science. 277:815–818. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sheridan JP, Marsters SA, Pitti RM, et al:
Control of TRAIL-induced apoptosis by a family of signaling and
decoy receptors. Science. 277:818–821. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ivanov VN, Partridge MA, Johnson GE, Huang
SX, Zhou H and Hei TK: Resveratrol sensitizes melanomas to TRAIL
through modulation of antiapoptotic gene expression. Exp Cell Res.
314:1163–1176. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee TJ, Um HJ, Min do S, Park JW, Choi KS
and Kwon TK: Withaferin A sensitizes TRAIL-induced apoptosis
through reactive oxygen species-mediated up-regulation of death
receptor 5 and down-regulation of c-FLIP. Free Radic Biol Med.
46:1639–1649. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jung EM, Lim JH, Lee TJ, Park JW, Choi KS
and Kwon TK: Curcumin sensitizes tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL)-induced apoptosis through
reactive oxygen species-mediated upregulation of death receptor 5
(DR5). Carcinogenesis. 26:1905–1913. 2005. View Article : Google Scholar
|
|
6
|
You BR and Park WH: The effects of
antimycin A on endothelial cells in cell death, reactive oxygen
species and GSH levels. Toxicol In Vitro. 24:1111–1118. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cai J and Jones DP: Superoxide in
apoptosis. Mitochondrial generation triggered by cytochrome c loss.
J Biol Chem. 273:11401–1144. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pham NA, Robinson BH and Hedley DW:
Simultaneous detection of mitochondrial respiratory chain activity
and reactive oxygen in digitonin-permeabilized cells using flow
cytometry. Cytometry. 41:245–251. 2000. View Article : Google Scholar
|
|
9
|
Turrens JF: Superoxide production by the
mitochondrial respiratory chain. Biosci Rep. 17:3–8. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pastorino JG, Tafani M, Rothman RJ,
Marcinkeviciute A, Hoek JB and Farber JL: Functional consequences
of the sustained or transient activation by Bax of the
mitochondrial permeability transition pore. J Biol Chem.
274:31734–31739. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Petronilli V, Penzo D, Scorrano L,
Bernardi P and Di Lisa F: The mitochondrial permeability
transition, release of cytochrome c and cell death. Correlation
with the duration of pore openings in situ. J Biol Chem.
276:12030–12034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee TJ, Jung EM, Lee JT, et al:
Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis
by down-regulation of XIAP gene promoter through Sp1 sites. Mol
Cancer Ther. 5:2737–2746. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moon DO, Kim MO, Choi YH and Kim GY:
Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis
via extracellular signal-regulated kinase/Sp1-dependent DR5
upregulation and NF-kappaB inactivation. Mol Cancer Ther.
9:1583–1595. 2010. View Article : Google Scholar
|
|
14
|
Frese-Schaper M, Schardt JA, Sakai T,
Carboni GL, Schmid RA and Frese S: Inhibition of tissue
transglutaminase sensitizes TRAIL-resistant lung cancer cells
through upregulation of death receptor 5. FEBS Lett. 584:2867–2871.
2010. View Article : Google Scholar
|
|
15
|
Fan S, Li Y, Yue P, Khuri FR and Sun SY:
The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments
TRAIL-mediated apoptosis through c-FLIP down-regulation and DR5
induction independent of inhibition of cap-dependent protein
translation. Neoplasia. 12:346–356. 2010.
|
|
16
|
Son YG, Kim EH, Kim JY, et al: Silibinin
sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5
up-regulation and down-regulation of c-FLIP and survivin. Cancer
Res. 67:8274–8284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim YH, Jung EM, Lee TJ, et al:
Rosiglitazone promotes tumor necrosis factor-related
apoptosis-inducing ligand-induced apoptosis by reactive oxygen
species-mediated up-regulation of death receptor 5 and
down-regulation of c-FLIP. Free Radic Biol Med. 44:1055–1068. 2008.
View Article : Google Scholar
|
|
18
|
Jang JH, Lee TJ, Yang ES, et al: Compound
C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis
through reactive oxygen species-mediated down-regulation of c-FLIPL
and Mcl-1. Exp Cell Res. 316:2194–2203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kauh J, Fan S, Xia M, et al: c-FLIP
degradation mediates sensitization of pancreatic cancer cells to
TRAIL-induced apoptosis by the histone deacetylase inhibitor
LBH589. PLoS One. 5:e103762010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poukkula M, Kaunisto A, Hietakangas V, et
al: Rapid turnover of c-FLIPshort is determined by its unique
C-terminal tail. J Biol Chem. 280:27345–27355. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaunisto A, Kochin V, Asaoka T, et al:
PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and
stability. Cell Death Differ. 16:1215–1226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li W, Zhang X and Olumi AF: MG-132
sensitizes TRAIL-resistant prostate cancer cells by activating
c-Fos/c-Jun heterodimers and repressing c-FLIP(L). Cancer Res.
67:2247–2255. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Benayoun B, Baghdiguian S, Lajmanovich A,
et al: NF-kappaB-dependent expression of the antiapoptotic factor
c-FLIP is regulated by calpain 3, the protein involved in
limb-girdle muscular dystrophy type 2A. FASEB J. 22:1521–1529.
2008. View Article : Google Scholar
|
|
24
|
Nitobe J, Yamaguchi S, Okuyama M, et al:
Reactive oxygen species regulate FLICE inhibitory protein (FLIP)
and susceptibility to Fas-mediated apoptosis in cardiac myocytes.
Cardiovasc Res. 57:119–128. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanayama A and Miyamoto Y: Apoptosis
triggered by phagocytosis-related oxidative stress through FLIPS
down-regulation and JNK activation. J Leukoc Biol. 82:1344–1352.
2007. View Article : Google Scholar : PubMed/NCBI
|
